Literature DB >> 3654059

The effect of diet on the ophthalmological, clinical and biochemical aspects of Richner-Hanhart syndrome: a morphological ultrastructural study of the cornea and the conjunctiva.

A Sammartino1, R Cerbella, A Cecio, G De Crecchio, A Federico, A Fronterre.   

Abstract

Type II tyrosinemia (Richner-Hanhart syndrome) is a familial aminoacid disorder, clinically characterized by ocular changes (keratitis), palmo-plantar hyperkeratosis, no constant mental changes with mental deterioration, abnormal urinary excretion and high serum tyrosine level in consequence of the absence of tyrosine-aminotransferase. Almost 20 families have been described in the literature of which 50% are of Italian origin, suggesting that this disorder is particularly frequent in our country. We report a family with 2 affected members with typical clinical and biochemical findings (keratitis, palmo-plantar hyperkeratosis, abnormal urinary and serum tyrosine concentrations), not suffering from mental retardation. Clinical symptoms completely disappeared after the decrease of urinary and serum tyrosine levels following a tyrosine- and phenylalanine-free diet. These cases are compared with those reported in literature, and the usefulness of diet for the improvement of clinical and metabolic symptoms is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654059     DOI: 10.1007/BF00155627

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  14 in total

1.  Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin-layer chromatography.

Authors:  R Humbel; M Collart
Journal:  Clin Chim Acta       Date:  1975-04-16       Impact factor: 3.786

2.  New special forms of keratosis palmo-plantaris, u. a., a regularly g-dominant with systematized lipomas, furthermore 2 simple-recessive with idiocy and z. T. with corneal changes in the eye (ectodermal syndrome).

Authors:  E HANHART
Journal:  Dermatologica       Date:  1947

3.  Bilateral keratopathy and tyrosinosis.

Authors:  H O Sandberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1975-11

4.  Familial tyrosinaemia with eye and skin lesions. Presentation of two cases.

Authors:  A M Bardelli; P Borgogni; M A Farnetani; A Fois; R Frezzotti; R Mattei; M Molinelli; I Sargentini
Journal:  Ophthalmologica       Date:  1977       Impact factor: 3.250

5.  Tyrosinemia with plantar and palmar keratosis and keratitis.

Authors:  L A Goldsmith; E Kang; D C Bienfang; K Jimbow; P Gerald; H P Baden
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

6.  Skin lesions in tyrosinosis: response to dietary treatment.

Authors:  W A Zaleski; A Hill; W Kushniruk
Journal:  Br J Dermatol       Date:  1973-04       Impact factor: 9.302

7.  An exceptional case of tyrosinosis.

Authors:  S K Wadman; F J van Sprang; J W Maas; D Ketting
Journal:  J Ment Defic Res       Date:  1968-12

8.  Oculocutaneous tyrosinosis. Report of two cases in the same family.

Authors:  L R Garibaldi; F Siliato; I de Martini; M R Scarsi; C Romano
Journal:  Helv Paediatr Acta       Date:  1977-07

9.  Crystals in corneal epithelial lesions of tyrosine-fed rats.

Authors:  I K Gipson; R P Burns; J D Wolfe-Lande
Journal:  Invest Ophthalmol       Date:  1975-12

10.  [Bilateral dendritic pseudokeratitis (Richner-Hanhart syndrome)].

Authors:  R Sundmacher
Journal:  Klin Monbl Augenheilkd       Date:  1977-01       Impact factor: 0.700

View more
  2 in total

Review 1.  From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.

Authors:  E A Lock; M K Ellis; P Gaskin; M Robinson; T R Auton; W M Provan; L L Smith; M P Prisbylla; L C Mutter; D L Lee
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

2.  Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC.

Authors:  P Gissen; M A Preece; H A Willshaw; P J McKiernan
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.